… for the patients treated with bortezomib [10–… systematic review and meta-analysis of clinical
trials to investigate the efficacy and safety of bortezomib for patients with previously untreated …

Full article: Bortezomib-based vs non-bortezomib-based post-transplantation treatment in
multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized …

… This study performed a meta-analysis of 22 RCTs to assess the efficacy and safety of thalidomide
for previously untreated MM patients, … (one study [12] had no power to assess OS). Our …

… systematic literature review and meta-analysis that assesses the efficacy and safety of
bortezomib-based retreatment in patients … /or refractory MM with previous exposure to bortezomib. …

… of bortezomib, subcutaneous and intravenous. Methods: Six retrospective studies and
three randomized controlled trials (RCTs) were included in our study. Data from retrospective …

… In 2011, the multiple myeloma guidelines of the … bortezomib/cyclophosphamide/dexamethasone
for transplant candidates; 2) the combination of bortezomib/dexamethasone for patients …

… induction therapy in patients with previously untreated myeloma. Overall, … patients, more
studies are still needed to assess clinical feasibility of such combinations. This systematic review …

… III randomized controlled trials (RCTs) that compared the outcomes of bortezomib-based
and non-bortezomib-based maintenance therapies in newly diagnosed MM patients. Included …

… systematic review of 4 randomized controlled trials and 8 retrospective trials comparing SC
to intravenous (IV) bortezomib … of this systematic review also suggested that SC bortezomib …

… Unlike lenalidomide, the role of bortezomib in the consolidation or maintenance … meta-analysis
of randomized controlled trials (RCTs) to examine the efficacy and safety of bortezomib-…